Ventyx Biosciences, Inc. announced the resignation of Christopher Krueger as Chief Business Officer of the Company, effective on April 15, 2024, to pursue other opportunities. Mr. Krueger?s resignation is voluntary and for personal reasons and is not the result of any disagreement with the Company related to its operations, policies, or practices. The Company thanks Mr. Krueger for his contributions to the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.91 USD | +4.91% | +20.94% | +98.79% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+98.79% | 330M | |
-1.65% | 104B | |
+6.75% | 97.47B | |
+5.71% | 22.25B | |
-12.60% | 21.68B | |
-9.70% | 18.2B | |
-39.98% | 17.02B | |
-10.17% | 16.36B | |
+6.12% | 14.39B | |
+35.47% | 12.37B |
- Stock Market
- Equities
- VTYX Stock
- News Ventyx Biosciences, Inc.
- Ventyx Biosciences, Inc. Announces Resignation of Christopher Krueger as Chief Business Officer, Effective on April 15, 2024